Ischemic Stroke News and Research

RSS

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

27 May 2011

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

The National Heart, Lung, and Blood Institute of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke.

27 May 2011

High IGF-I hormone levels linked with better long-term recovery after stroke

Insulin-like growth factor I, IGF-I, is a hormone that is found in the blood and contributes to, among other things, growth and bone mass. The levels of this hormone are higher in people who exercise regularly and those with good health. Scientists at the Sahlgrenska Academy have shown for the first time that high levels of this hormone are associated with better long-term recovery after a stroke.

17 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.

10 May 2011

Cholesterol-lowering drugs may help clot-busting drugs treat strokes

Cholesterol-lowering drugs known as statins may help clot-busting drugs treat strokes, according to researchers at Washington University School of Medicine in St. Louis.

27 Apr 2011

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

The Stanford University School of Medicine and SanBio Inc. today announced the initiation of a Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, on patients suffering from stable deficits resulting from previous stroke injuries.

21 Apr 2011

Neuralstem signs MoU with BaYi Brain Hospital for ischemic stroke program in China

Neuralstem, Inc. (NYSE Amex: CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China.

21 Apr 2011

Antidepressant medication improves physical recovery from stroke

A University of Iowa study finds that patients treated with a short course of antidepressants after a stroke have significantly greater improvement in physical recovery than patients treated with a placebo. Moreover, the study is the first to demonstrate that this physical recovery continues to improve for at least nine months after the antidepressant medication is stopped.

8 Apr 2011

Patients with stroke can benefit from antidepressants

8 Apr 2011

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.

6 Apr 2011

Sleep apnea people may face risk of suffering ischemic stroke

According to research presented at the School of Medicine and the University of Navarra Hospital by Dr. Roberto Muñoz, a physician of the Neurology Service of the Hospital Complex of Navarra, those persons with serious cases of sleep apnea have more than twice the possibility of suffering an ischemic stroke. Specifically, 2.5 times more.

6 Apr 2011

Reverse Medical's ReFlex A+ Catheter receives European CE mark approval

Reverse Medical Corporation announced today that it has received CE Mark for its ReFlex A+ Catheter for intracranial distal access, delivery and aspiration.

5 Apr 2011

Scientia Vascular's PLATO microcatheters granted CE mark

Scientia Vascular, developer of innovative products that are optimized for endovascular access and therapies, announced today that its PLATOTM Microcath has received CE Mark approval, facilitating availability for European neuro, cardio and peripheral endovascular applications.

31 Mar 2011

Allscripts ED 7.0 receives Complete EHR certification

Allscripts announced today that Allscripts ED™ 7.0, the company's standalone Emergency Department Information System (EDIS), is 2011/2012 compliant and was certified as a Complete EHR on March 2, 2011 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable hospital certification criteria adopted by the Secretary of Health and Human Services.

30 Mar 2011

Navy sonar experts develop new medical device for stroke detection

A medical device developed by retired U.S. Navy sonar experts, using submarine technology, is a new paradigm for the detection, diagnosis and monitoring of stroke, says a team of interventional radiologists at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

IMRIS sells IMRISNV to University of Utah Hospital

IMRIS Inc. today announced the sale of IMRISNV to University of Utah Hospital in Salt Lake City, Utah.

28 Mar 2011

Non-invasive brain stimulation improves swallowing ability among stroke survivors

Stroke patients who received electrical brain stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.

25 Mar 2011

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.

25 Mar 2011

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.

25 Mar 2011

Ischemic Stroke News and Research

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

High IGF-I hormone levels linked with better long-term recovery after stroke

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

Cholesterol-lowering drugs may help clot-busting drugs treat strokes

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

Neuralstem signs MoU with BaYi Brain Hospital for ischemic stroke program in China

Antidepressant medication improves physical recovery from stroke

Patients with stroke can benefit from antidepressants

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Sleep apnea people may face risk of suffering ischemic stroke

Reverse Medical's ReFlex A+ Catheter receives European CE mark approval

Scientia Vascular's PLATO microcatheters granted CE mark

Allscripts ED 7.0 receives Complete EHR certification

Navy sonar experts develop new medical device for stroke detection

IMRIS sells IMRISNV to University of Utah Hospital

Non-invasive brain stimulation improves swallowing ability among stroke survivors

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News